Stephen MacMahon AO's Publications

About Stephen MacMahon AO's Publications

Founding Director, The George Institute for Global Health
  • Professor of Cardiovascular Medicine, Faculty of Medicine, UNSW Sydney
  • Chair of Global Health, Faculty of Medicine, Imperial College of London
  • The determinants of fat intake in a multi-ethnic New Zealand population. Fletcher Challenge--University of Auckland Heart and Health Study Management Committee

    International Journal of Epidemiology Date published:
  • Effects of Lowering Average or Below-Average Cholesterol Levels on the Progression of Carotid Atherosclerosis

    Circulation Date published:
  • Blood pressure and the risk of recurrent vascular disease

    American Journal of Hypertension Date published:
  • Treatment for high blood pressure: evidence and practice

    Evidence-based Cardiovascular Medicine Date published:
  • Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments

    Journal of Hypertension Date published:
  • Pravastatin reduces total mortality in patients with coronary heart disease and average cholesterol levels: relationship of baseline cholesterol and treatment effects in the LIPID trial

    Journal of the American College of Cardiology Date published:
  • Monitoring clinical trials

    NEW ZEALAND MEDICAL JOURNAL Date published:
  • 3.1 Stroke, coronary heart disease, cholesterol and blood pressure

    Journal of Hypertension Date published:
  • Use of the Friedewald Formula to Estimate LDL-Cholesterol in Patients with Chronic Renal Failure on Dialysis

    Clinical Chemistry Date published:
  • Reliable and unbiased assessment of the effects of calcium antagonists

    Journal of Hypertension Date published:
  • Migraine: a risk factor for motor vehicle driver injury?

    Accident Analysis & Prevention Date published:
  • Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding

    Journal of Human Hypertension Date published:
  • Effects of beta-blocker therapy on mortality in patients with heart failure: A systematic overview of randomized controlled trials

    European Heart Journal Date published:
  • Left Ventricular Remodeling With Carvedilol in Patients With Congestive Heart Failure Due to Ischemic Heart Disease fn1fn1This study was funded by a grant from SmithKline Beecham; however, the study was initiated, conducted, analyzed and reported by the Australia-New Zealand Heart Failure Research Collaborative Group independently of the sponsor. The Clinical Trials Research Unit is supported by a programme grant from the Health Research Council of New Zealand.

    Journal of the American College of Cardiology Date published:
  • Blood Pressure Lowering for the Secondary Prevention of Myocardial Infarction and Stroke

    Hypertension Date published:
  • Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease

    The Lancet Date published: